MiR-143-3p serves as a novel biomarker for diabetic cardiomyopathy and is involved in regulating high glucose-induced cardiomyocyte injury
- DOI
- 10.1177/14791641261454501
- Published
- 2026-07
- Container
- Diabetes & Vascular Disease Research
- Publisher
- SAGE Publications
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1177/14791641261454501,
title = {MiR-143-3p serves as a novel biomarker for diabetic cardiomyopathy and is involved in regulating high glucose-induced cardiomyocyte injury},
author = {Zhengnan Zhang and Suyun Wang and Liping Zhu and Yang Bian and Jing Zhao},
year = {2026},
journal = {Diabetes \& Vascular Disease Research},
doi = {10.1177/14791641261454501},
url = {https://doi.org/10.1177/14791641261454501}
}RIS
TY - JOUR TI - MiR-143-3p serves as a novel biomarker for diabetic cardiomyopathy and is involved in regulating high glucose-induced cardiomyocyte injury AU - Zhengnan Zhang AU - Suyun Wang AU - Liping Zhu AU - Yang Bian AU - Jing Zhao PY - 2026 JO - Diabetes & Vascular Disease Research DO - 10.1177/14791641261454501 UR - https://doi.org/10.1177/14791641261454501 ER -
APA
Zhang, Z., Wang, S., Zhu, L., Bian, Y., & Zhao, J. (2026). MiR-143-3p serves as a novel biomarker for diabetic cardiomyopathy and is involved in regulating high glucose-induced cardiomyocyte injury. Diabetes & Vascular Disease Research. https://doi.org/10.1177/14791641261454501
Source records
- crossref · retrieved 2026-09-26T01:40:40.327Z